You have 9 free searches left this month | for more free features.

Condition

Food-drug Interaction (1)

Lung Cancer Metastatic (1)

Lung Cancer Stage IV (1)

Lung Cancer, Nonsmall Cell (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

SignalChem Lifesciences Corporation (2)

Collaborator

Merck Sharp & Dohme LLC (1)

Syneos Health (1)

Intervention

slc-391 (2)

pembrolizumab (1)

Study Documents

Intervention Type

drug (2)

biological (1)

Funder Type

Industry (2)

Study Type

Interventional (2)

slc-391

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Lung Cancer, Nonsmall Cell, Lung Cancer Stage IV, Lung Cancer Metastatic Trial in Canada, United States (SLC-391, Pembrolizumab)

Not yet recruiting

Lung Cancer, Nonsmall Cell
+2 more

SLC-391
Pembrolizumab

Indianapolis, Indiana
+8 more

May 5, 2023

Food-drug Interaction Trial in Quebec (SLC-391)

Completed

Food-drug Interaction

SLC-391

Quebec, Canada

Syneos Health Clinique Inc. (Quebec)

Jul 28, 2022